NCT02400281View on ClinicalTrials.gov

Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Crenolanib besylate

DRUG

Idarubicin

DRUG

Cytarabine

DRUG

Azacytidine

DRUG

Mitoxantrone

DRUG

Etoposide

DRUG

Fludarabine

DRUG

G-CSF

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Arog Pharmaceuticals, Inc.

INDUSTRY